Pa­tients with the most com­mon KRAS mu­ta­tion in pan­cre­at­ic can­cer ap­peared to have a low­er re­sponse rate than the over­all pa­tient pop­u­la­tion with Rev­o­lu­tion Med­i­cines’...

The act­ing gen­er­al coun­sel at HHS, Bob Fos­ter, is no longer at the agency.

When End­points Newscon­tact­ed Fos­ter through his gov­ern­ment email, it re­ceived...